REN and chronic kidney disease: Renin–angiotensin–aldosterone system (RAAS) inhibitors, including ACE inhibitors (enalapril, lisinopril, ramipril) and ARBs (losartan, valsartan, Irbesartan), remain the cornerstone for slowing CKD progression—particularly in proteinuric patients [7].